Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 301.94B, Merck(MRK) trades at $121.20. The stock has a price-to-earnings ratio of 16.70 and currently yields dividends of 2.7%.
As of 2026-02-18, Merck(MRK) stock has fluctuated between $120.80 and $122.99. The current price stands at $121.20, placing the stock +0.3% above today's low and -1.5% off the high.
The Merck(MRK)'s current trading volume is 9.9M, compared to an average daily volume of 15.72M.
In the last year, Merck(MRK) shares hit a 52-week high of $123.33 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $123.33 and a 52-week low of $73.31.
MRK News
Merck (MRK) announced that Health Canada has approved KEYTRUDA SC, a new subcutaneous formulation of pembrolizumab, Merck’s anti-PD-1 therapy. The approval is b...
In early February 2026, Merck received FDA approval for KEYTRUDA and KEYTRUDA QLEX plus paclitaxel, with or without bevacizumab, for adults with PD-L1 positive,...
Advertisement Why Merck stock is back in focus Merck (MRK) is back on investors radars after the FDA approved KEYTRUDA and its subcutaneous QLEX formulation f...
Analyst ratings
59%
of 29 ratingsMore MRK News
Insiders have been trading these 5 stocks: ((PG)), ((DAL)), ((MRK)), ((CCL)) and ((RTX)). Here is a breakdown of their recent trades and their value. Insider s...
And now may be the right time to look for something other than artificial intelligence (AI)-driven growth. What's been a fantastic few years for growth stocks...
Merck (NYSE:MRK) received FDA approval for KEYTRUDA and subcutaneous KEYTRUDA QLEX for platinum resistant ovarian cancer, including a companion diagnostic. The...
Some Merck & Co., Inc. ( ) shareholders may be a little concerned to see that the Chairman, Robert Davis, recently sold a substantial US$5.6m worth of stock at...
Many investors are asking whether Merck's current share price really lines up with its underlying worth, or if the stock might be offering more value than it ap...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and be...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.